News|Articles|February 21, 2024
Upstream Intensification – Enabling Perfusion Processes with Cell Retention Technologies
Author(s)Millipore Sigma
This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
5